Progress In Fight Against Malaria, As New Treatment Shows Promise
The anti-malarial GanLum's Phase 3 data highlight the drug's potential to further combat the threat of antimalarial drug resistance in Africa.
(Forbes, 2025-12-01T21:29:06Z)